Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
Main Authors: | Wei-Ru Chiou, Po-Lin Lin, Chun-Che Huang, Jen-Yu Chuang, Lawrence Yu-Min Liu, Min-I Su, Feng-Ching Liao, Jen-Yuan Kuo, Cheng-Ting Tsai, Yih-Jer Wu, Kuang-Te Wang, Ying-Hsiang Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-30971-8 |
Similar Items
-
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
by: Wei-Ru Chiou, et al.
Published: (2022-03-01) -
Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation
by: Wei-Ru Chiou, et al.
Published: (2023-10-01) -
Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy
by: Yoon-Kee Siow, et al.
Published: (2024-01-01) -
Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control
by: Shaojie Chen, et al.
Published: (2022-11-01) -
Clinical Characteristics and Rhythm Outcomes in Patients With Atrial Myopathy After Successful Catheter Ablation of Atrial Fibrillation
by: Moon‐Hyun Kim, et al.
Published: (2024-02-01)